TMBC membership encompasses a broad spectrum of stakeholders from industry, spanning companies working on microbiome based therapeutic modalities, diagnostics, direct-to-consumer products and services and other related constituencies. Membership is open, but not limited, to commercial companies offering an array of products and services including research tools, diagnostic technologies and products, screening services and therapeutic interventions and direct-to-consumer products and services. Membership in TMBC is equally open to universities and academic medical centers, non-profit research entities, relevant trade associations, patient advocacy groups, government officials (ex-officio), health care organizations, health care providers, payers and information technology companies.
See below for a full list of our current members.
Emerging Biotech/Pharmaceutical Companies
Clinical Care Institutions
Research Service Providers
Health Insurance Companies